SandraBlanco Benavente Universidad de SalamancaSpain

SandraBlanco Benavente
During my PhD and my post-doctorate, I have been engaged in finding the molecular mechansms that lead to cancer. Initially during my PhD, at the Institute of Molecular and Cellular Biology of Cancer (Salamanca, Spain), I studied post-translation modifications and particularly dysfunctional phosphorylation pathways as possible targets for cancer therapy. I obtained my Ph.D. Degree in Molecular Biology of Cancer from the University of Salamanca in June 2006. Following the completion of my Ph.D., I joined the group of Pr. Michaela Frye at the Wellcome Trust – MRC Cambridge Stem Cell Institute – University of Cambridge, to study the molecular basis of epidermal stem cell functions, and the functional role of post-transcriptional RNA modifications in tissue homeostasis and the impact of their dysregulation in neurodevelopmental disorders and cancer. My work focused on the functional role of 5-methylcytosine deposition in transfer RNA. In October 2016, I was awarded a Ramón y Cajal fellowship and I was appointed junior investigator at the CIC bioGUNE in Spain. In August 2018 I was appointed a permanent position as a group leader of the Spanish Research Council at the Cancer Research Centre in Salamanca, Spain.

Monday 08 June 2026

Time Session
12:30
13:45
Networking Event for Early-Career Attendees
(open to EACR Early Career & Student Members, pre-registration required)
Career Development Area

Tuesday 09 June 2026

Time Session
11:35
13:10
Symposium: Cancer and RNA Modifications
Room F9+10